Literature DB >> 14557383

The pathogenic roles of tumor necrosis factor receptor p55 in acetaminophen-induced liver injury in mice.

Yuko Ishida1, Toshikazu Kondo, Koichi Tsuneyama, Peirong Lu, Tatsunori Takayasu, Naofumi Mukaida.   

Abstract

Acetaminophen (APAP) causes a massive production of intrahepatic tumor necrosis factor alpha (TNF-alpha). However, it still remains elusive regarding the roles of TNF-alpha in APAP-induced liver injury. Hence, we examined pathogenic roles of the TNF-alpha-TNF receptor with a molecular weight of 55 kDa (TNF-Rp55) axis in APAP-induced hepatotoxicity using TNF-Rp55-deficient [TNF-Rp55-knockout (KO)] mice. When wild-type (WT) BALB/c and TNF-Rp55-KO mice were intraperitoneally injected with a lethal dose of APAP (750 mg/kg), the mortality of TNF-Rp55-KO mice was marginally but significantly reduced compared with WT mice. Upon treatment with a nonlethal dose (600 mg/kg), WT mice exhibited an increase in serum transaminase levels. Histopathologically, centrilobular hepatic necrosis with leukocyte infiltration was evident at 10 and 24 h after APAP challenge. Moreover, mRNA expression of adhesion molecules, several chemokines, interferon-gamma (IFN-gamma), and inducible nitric oxide synthase (iNOS) was enhanced in the liver. On the contrary, serum transaminase elevation and histopathological changes were attenuated in TNF-Rp55-KO mice injected with APAP (600 mg/kg). The gene expression of all molecules except for IFN-gamma and iNOS was significantly attenuated in TNF-Rp55-KO mice. Moreover, anti-TNF-alpha neutralizing antibodies alleviated liver injury when administered at 2 or 8 h after but not at 1 h before APAP challenge to WT mice. Collectively, the TNF-alpha-TNF-Rp55 axis has pathogenic roles in APAP-induced liver failure.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14557383     DOI: 10.1189/jlb.0403152

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  32 in total

1.  The dual role of osteopontin in acetaminophen hepatotoxicity.

Authors:  Chun-yan He; Bei-bei Liang; Xiao-yu Fan; Lei Cao; Rui Chen; Ya-jun Guo; Jian Zhao
Journal:  Acta Pharmacol Sin       Date:  2012-06-25       Impact factor: 6.150

2.  The role of hypoxia-inducible factor-1α in acetaminophen hepatotoxicity.

Authors:  Erica M Sparkenbaugh; Yogesh Saini; Krista K Greenwood; John J LaPres; James P Luyendyk; Bryan L Copple; Jane F Maddox; Patricia E Ganey; Robert A Roth
Journal:  J Pharmacol Exp Ther       Date:  2011-05-16       Impact factor: 4.030

3.  Liuweiwuling tablets protect against acetaminophen hepatotoxicity: What is the protective mechanism?

Authors:  Kuo Du; Hartmut Jaeschke
Journal:  World J Gastroenterol       Date:  2016-03-21       Impact factor: 5.742

4.  Aberrant expression of histo-blood group A type 3 antigens in vascular endothelial cells in inflammatory sites.

Authors:  Mizuho Nosaka; Yuko Ishida; Aki Tanaka; Takahito Hayashi; Tomoko Miyashita; Chikako Kaminaka; Wolfgang Eisenmenger; Fukumi Furukawa; Akihiko Kimura
Journal:  J Histochem Cytochem       Date:  2007-11-12       Impact factor: 2.479

5.  Effect of trifluoperazine on toxicity, HIF-1α induction and hepatocyte regeneration in acetaminophen toxicity in mice.

Authors:  Shubhra Chaudhuri; Sandra S McCullough; Leah Hennings; Aliza T Brown; Shun-Hwa Li; Pippa M Simpson; Jack A Hinson; Laura P James
Journal:  Toxicol Appl Pharmacol       Date:  2012-08-10       Impact factor: 4.219

6.  Tumor necrosis factor alpha is a proximal mediator of synergistic hepatotoxicity from trovafloxacin/lipopolysaccharide coexposure.

Authors:  Patrick J Shaw; Patricia E Ganey; Robert A Roth
Journal:  J Pharmacol Exp Ther       Date:  2008-09-26       Impact factor: 4.030

7.  Increased susceptibility of natural killer T-cell-deficient mice to acetaminophen-induced liver injury.

Authors:  Brittany V Martin-Murphy; Douglas J Kominsky; David J Orlicky; Terrence M Donohue; Cynthia Ju
Journal:  Hepatology       Date:  2013-01-18       Impact factor: 17.425

8.  An integrative genomic analysis identifies Bhmt2 as a diet-dependent genetic factor protecting against acetaminophen-induced liver toxicity.

Authors:  Hong-Hsing Liu; Peng Lu; Yingying Guo; Erin Farrell; Xun Zhang; Ming Zheng; Betty Bosano; Zhaomei Zhang; John Allard; Guochun Liao; Siyu Fu; Jinzhi Chen; Kimberly Dolim; Ayako Kuroda; Jonathan Usuka; Janet Cheng; William Tao; Kevin Welch; Yanzhou Liu; Joseph Pease; Steve A de Keczer; Mohammad Masjedizadeh; Jing-Shan Hu; Paul Weller; Tim Garrow; Gary Peltz
Journal:  Genome Res       Date:  2009-11-18       Impact factor: 9.043

9.  Screening for Toxoplasma gondii-regulated transcriptional responses in lipopolysaccharide-activated macrophages.

Authors:  Chiang W Lee; Soumaya Bennouna; Eric Y Denkers
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

Review 10.  Current concepts of mechanisms in drug-induced hepatotoxicity.

Authors:  Stefan Russmann; Gerd A Kullak-Ublick; Ignazio Grattagliano
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.